References
- Dodé C, Hardelin JP. Kallmann syndrome. Eur J Hum Genet. 2009;17(2):139.
- Hardelin J-P, DodÉ C. The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al. Sex Dev. 2008;2(4–5):181–193.
- Kim SH. Congenital hypogonadotropic hypogonadism and kallmann syndrome: past, present, and future. Endocrinol Metab. 2015;30(4):456–466.
- Wierman ME, Kiseljak-Vassiliades K, Tobet S. Gonadotropin-releasing hormone (GnRH) neuron migration: initiation, maintenance and cessation as critical steps to ensure normal reproductive function. Front Neuroendocrinol. 2011;32(1):43–52.
- Forni PE, Wray S. GnRH, anosmia and hypogonadotropic hypogonadism–where are we? Front Neuroendocrinol. 2015;36:165–177.
- Boehm U, Bouloux P-M, Dattani MT, et al. Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism—pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2015;11(9):547.
- Ha J-H, Lee S, Kim Y, et al. Kallmann syndrome with a Tyr113His PROKR2 mutation. Medicine. 2017;96(35):e7974.
- Fukunishi A, Maruyama T, Zhao H, et al. The action of Semaphorin7A on thalamocortical axon branching. J Neurochem. 2011;118(6):1008–1015.
- Pasterkamp RJ, Peschon JJ, Spriggs MK, et al. Semaphorin 7A promotes axon outgrowth through integrins and MAPKs. Nature. 2003;424(6947):398.
- Messina A, Ferraris N, Wray S, et al. Dysregulation of Semaphorin7A/β1-integrin signaling leads to defective GnRH-1 cell migration, abnormal gonadal development and altered fertility. Hum Mol Genet. 2011;20(24):4759–4774.
- Känsäkoski J, Fagerholm R, Laitinen EM, et al. Mutation screening of SEMA3A and SEMA7A in patients with congenital hypogonadotropic hypogonadism. Pediatr Res. 2014;75(5):641.
- Miura K, Miura S, Yoshiura K, et al. A case of Kallmann syndrome carrying a missense mutation in alternatively spliced exon 8A encoding the immunoglobulin-like domain IIIb of fibroblast growth factor receptor 1. Hum Reprod. 2010;25(4):1076–1080.
- Kallmann FJ. The genetic aspects of primary eunuchoidism. Am J Mental Defic. 1944;48:203–236.
- Ogier JM, Arhatari BD, Carpinelli MR, et al. An intronic mutation in Chd7 creates a cryptic splice site, causing aberrant splicing in a mouse model of CHARGE syndrome. Sci Rep. 2018;8(1):5482.
- Hwang DY, Hung CC, Riepe FG, et al. CYP17A1 intron mutation causing cryptic splicing in 17α-hydroxylase deficiency. PloS One. 2011;6(9):e25492.
- Skałba P, Guz M. Hypogonadotropic hypogonadism in women. Endokrynol Pol. 2011;62(6):560–567.
- Pitteloud N, Quinton R, Pearce S, et al. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J Clin Invest. 2007;117(2):457–463.
- Cole LW, Sidis Y, Zhang CK, et al. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum. J Clin Endocrinol Metabol. 2008;93(9):3551–3559.
- Sarfati J, Guiochon-Mantel A, Rondard P, et al. A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes. J Clin Endocrinol Metabol. 2010;95(2):659–669.